| Literature DB >> 30202050 |
J Matthew Barnes1, Shelly Kaushik1, Russell O Bainer1, Jason K Sa2,3, Elliot C Woods4, FuiBoon Kai1, Laralynne Przybyla1, Mijeong Lee2,5, Hye Won Lee2,6, Jason C Tung1, Ori Maller1, Alexander S Barrett7, Kan V Lu8, Jonathon N Lakins1, Kirk C Hansen7, Kirsten Obernier8,9, Arturo Alvarez-Buylla8,9, Gabriele Bergers8,10, Joanna J Phillips8, Do-Hyun Nam2,5,11, Carolyn R Bertozzi4, Valerie M Weaver12,13,14,15.
Abstract
Glioblastoma multiforme (GBMs) are recurrent lethal brain tumours. Recurrent GBMs often exhibit mesenchymal, stem-like phenotypes that could explain their resistance to therapy. Analyses revealed that recurrent GBMs have increased tension and express high levels of glycoproteins that increase the bulkiness of the glycocalyx. Studies showed that a bulky glycocalyx potentiates integrin mechanosignalling and tissue tension and promotes a mesenchymal, stem-like phenotype in GBMs. Gain- and loss-of-function studies implicated integrin mechanosignalling as an inducer of GBM growth, survival, invasion and treatment resistance, and a mesenchymal, stem-like phenotype. Mesenchymal-like GBMs were highly contractile and expressed elevated levels of glycoproteins that expanded their glycocalyx, and they were surrounded by a stiff extracellular matrix that potentiated integrin mechanosignalling. Our findings suggest that there is a dynamic and reciprocal link between integrin mechanosignalling and a bulky glycocalyx, implying a causal link towards a mesenchymal, stem-like phenotype in GBMs. Strategies to ameliorate GBM tissue tension offer a therapeutic approach to reduce mortality due to GBM.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30202050 PMCID: PMC6932748 DOI: 10.1038/s41556-018-0183-3
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824